9/26/2023 | 30049099 | (100% EOU) (FOC) OLFEN 100MG RECTAL CAPSULES - BATCH NO.1850213 (FOR RESEARCH & TESTING PURPOSES ONLY) | XXXXXXXXXX | 25 | PCS | 16.38 | SWITZERLAND | BASLE |
9/16/2023 | 30049099 | LEE011 204.082MG/G POWDER ORAL 14.7G | XXXXXXXXXX | 100 | PCS | 9260.38 | SWITZERLAND | BASLE |
9/15/2023 | 30049099 | TMT212 2MG TABLET BATCH 1010050581 (TL/CT/23/000182 DATE 21.08.2023) (CLINICAL TRIAL) (FOC) | XXXXXXXXXX | 1280 | PCS | 34335.48 | SWITZERLAND | BASLE |
9/15/2023 | 30049099 | DRB436 50MG CAPSULE BATCH 1000048889 (TL/CT/23/000182 DATE 21.08.2023) (CLINICAL TRIAL) (FOC) | XXXXXXXXXX | 560 | PCS | 2833.81 | SWITZERLAND | BASLE |
9/15/2023 | 30049099 | DRB436 75MG CAPSULE BATCH 1000050218 (TL/CT/23/000182 DATE 21.08.2023) (CLINICAL TRIAL) (FOC) | XXXXXXXXXX | 5600 | PCS | 44238.25 | SWITZERLAND | BASLE |
9/15/2023 | 30049099 | DRB436 50MG CAPSULE BATCH 1010050216 (TL/CT/23/000182 DATE 21.08.2023) (CLINICAL TRIAL) (FOC) | XXXXXXXXXX | 2800 | PCS | 14169.06 | SWITZERLAND | BASLE |
9/15/2023 | 30049099 | TMT212 0.5MG TABLET BATCH 1010042928 (TL/CT/23/000182 DATE 21.08.2023) (CLINICAL TRIAL) (FOC) | XXXXXXXXXX | 1600 | PCS | 13042.5 | SWITZERLAND | BASLE |
9/15/2023 | 30049099 | DRB436 75MG CAPSULE BATCH 1010024350 (TL/CT/23/000182 DATE 21.08.2023) (CLINICAL TRIAL) (FOC) | XXXXXXXXXX | 700 | PCS | 5529.78 | SWITZERLAND | BASLE |
9/11/2023 | 30049099 | DRB436 75MG CAPSULE BATCH 1010050218 (TL/CT/23/000182 DATE 21/08/2023) (CLINICAL TRIAL) (FOC) | XXXXXXXXXX | 2800 | PCS | 22696.15 | SWITZERLAND | BASLE |
9/11/2023 | 30049099 | TMT212 2MG TABLET BATCH 1010050581 (TL/CT/23/000182 DATE 21/08/2023) (CLINICAL TRIAL) (FOC) | XXXXXXXXXX | 3200 | PCS | 88000.23 | SWITZERLAND | BASLE |